NasdaqCM:NKTRPharmaceuticals
Nektar Names Linda Rubinstein CFO As Funding And Dilution Questions Loom
Nektar Therapeutics (NasdaqCM:NKTR) has appointed Linda Rubinstein as Chief Financial Officer.
Rubinstein succeeds retiring CFO Sandra Gardiner and brings experience in large M&A and capital markets transactions.
Nektar Therapeutics is drawing fresh attention with this leadership change, coming after a very large 1 year share price gain and a year to date return of 55.6%. The stock last closed at $67.58, even after declining 13.8% over the past week and 20.4% over the past month.
For...